[Retracted] Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study

Table 2

Comparison of liver function indexes between groups ().

Grouping	N	AST (U/L)		ALT (U/L)		TBIL (μmol/L)
		Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Observation group	72	85.36 ± 1.25	41.85 ± 1.04^a	95.14 ± 1.32	54.48 ± 1.16^a	102.43 ± 1.18	62.58 ± 1.07^a
Control group	72	85.75 ± 1.43	58.12 ± 1.18^b	95.48 ± 1.25	63.87 ± 1.04^b	102.58 ± 1.12	74.66 ± 1.15^b
t-value		1.742	87.772	1.587	51.142	0.782	65.255
P-value		＞0.05	＜0.05	＞0.05	＜0.05	＞0.05	＜0.05

Note. Compared to observation group before treatment, ^aP < 0.05. Compared to control group before treatment, ^bP < 0.05.